Multimodal surgical strategy for mixed refractory hypertonia in a patient with cerebral palsy: C1–2 puncture and pectoral pocket for baclofen pump implantation following lumbosacral ventral-dorsal rhizotomy. Illustrative case Authors: Shreya Mukherjee, Sunny Abdelmageed, Maryam N. Shahin, Jeffrey S. Raskin Published: 2024 ABSTRACT BACKGROUNDIntrathecal baclofen pump (ITBP) therapy has been successfully used to treat hypertonia in children with cerebral palsy (CP) since its Food and Drug Administration approval in 1984. CP affects multiple organ systems, leading to the accumulation of medical access and implantable devices, increasing the medical complexity of these children. The authors present the case of a patient with extreme surgical complexity and review the medical decision-making and surgical details.OBSERVATIONSA 16-year-old male with a history of quadriplegic mixed hypertonia secondary to CP presented for ITBP replacement in the setting of pump end of service (EOS). The patient had short bowel syndrome (SBS) and severe scoliosis with a nonhealing costopelvic wound adjacent to the EOS pump. Intrathecal baclofen wean failed due to limited bioavailability from the SBS. The authors performed catheter placement to the skull base via a right C1–2 puncture and pectoral pump pocket creation. Treatment was well tolerated, with no procedural complications.LESSONSSurgical complexity prompts creative problem-solving. It is critical to consider the nuances of each patient’s history and body habitus to promote ITBP longevity. The authors present the case of a patient with CP who underwent catheter access via C1–2 puncture and pectoral pocket creation. In this case, surgery was effective, with an uncomplicated postoperative course. Surgeons should not hesitate to consider alternative implantation strategies in similar circumstances. https://thejns.org/doi/10.3171/CASE24427 Spasticity is a neurological disorder in children, commonly associated with cerebral palsy (CP), and is mediated by upper motor neuron loss and subsequent constitutively active myotatic reflexes.1, 2 These increase positive signs, such as clonus and spasms, and negative features, such as paresis and loss of the autonomic postural response.2 Spasticity is the dominant motor symptom in CP, with the spastic CP subtype estimated to represent 78%–88% of CP cases.3, 4 Dystonia is another common form of pediatric movement disorder (PMD) caused by CP, defined as involuntary sustained or fluctuating muscle contractions, resulting in abnormal movement and postures.5 Dystonia often causes a biomechanical twisting of the limb or spine and leads to bone and joint deformity. Both forms of PMD presented are forms of hypertonia, and they can become severe and resistant to medical therapy. Mixed medically refractory hypertonia (MRH) is severe and requires neurosurgical management. An intrathecal baclofen pump (ITBP) and rhizotomy are two commonly used neurosurgical approaches to treat mixed MRH. ITBP catheters are typically placed percutaneously in the lumbar spine via the interlaminar space and advanced to either the cervical or thoracic spine, targeted to treat the patient’s most affected limbs.6 Patients with CP often have several comorbidities including neuromuscular scoliosis, which can preclude the technical feasibility of ITBP implantation.7 Alternative approaches have been utilized in patients whose anatomy is challenging, including intraventricular baclofen at the third ventricle,8 open approaches to the foramen magnum,9 laminectomy/laminotomy for access to the cervical spine,10, 11 and percutaneous C1–2 puncture.6 The placement of intraventricular catheters for baclofen has previously been described as technically demanding,6 requiring endoscopic assistance to place the catheter in the third ventricle.8, 12 Alternative places for the pump have been previously described, including the iliac fossa, thigh, and chest.13–15 We present the case of a 16-year-old male with CP and mixed quadriplegic MRH with an end-of-service (EOS) left abdominal pump and prior lumbar ITBP catheter who previously underwent a lumbosacral (LS) ventral-dorsal rhizotomy (VDR). His pump location was surrounded by enteral access devices and open wounds and was thought to be at very high risk for infection. We describe treatment with a direct C1–2 puncture with catheter placement to C0. The technique of C1–2 cisternal puncture has been previously described and is well practiced.6, 16–18 However, to our knowledge, C1–2 catheter access and pectoral pocket creation in such a complex patient is undescribed, and the nuances of medical and surgical decision-making are explored. Illustrative Case History and Examination A 16-year-old male with CP and severe quadriplegic mixed MRH, Gross Motor Function Classification System level V, presented for ITBP replacement due to EOS. The patient had comorbidities, including a history of severe prematurity, Lennox-Gastaut syndrome with vagus nerve stimulator (VNS) placement, thoracolumbar and LS scoliosis, prior necrotizing enterocolitis, and a complex gastrointestinal surgical history, contributing to complex functional and mobility issues classified as “short bowel syndrome” (SBS). Seven years earlier, the patient had undergone initial ITBP placement after trialing enteral baclofen and extensive therapy. The catheter was successfully inserted via a traditional lumbar puncture at L1, and the reservoir was placed in a subcutaneous pocket in his left abdomen inferior to the gastrostomy tube. In the years following this surgery, the patient had several abdominal procedures and infections. Upon presentation, the patient’s ITBP was EOS. His leg hypertonia was much improved due to the LS VDR, but his head, neck, trunk, and arms remained with modified Ashworth Scale (mAS) grade 4 and severe dystonia; consequently, we believed that he would benefit from a catheter revision from the thoracic to the cervical spine. Due to the local surgical complexity and nonhealing wound between the catheter and pump, we discussed weaning the ITBP and performing a pallidotomy, revising the pump in situ, and implanting a new pump and catheter system in alternative locations (e.g., chest, thigh, and back). We dismissed revising in situ due to an elevated but unquantifiable risk of infection. The family declined pump placement in the back or thigh and opted for ITBP wean and pallidotomy. Before the wean began, the patient had been receiving 880 µg baclofen daily through the ITBP. The planned protocol for the ITBP wean was to decrease the patient’s intrathecal baclofen (ITB) dose by 15% daily and increase enteral medications, as possible. However, the reduction of intrathecal medicine with the concurrent supplementation of enteral antispasmodics was unsuccessful due to the patient’s SBS—a result of multiple abdominal surgeries including Roux-en-Y reconstruction and pyloroplasty, subtotal colectomy, ileostomy, jejunal resection, and jejunostomy—and the bioavailability of enteral baclofen was inadequate. The patient experienced worsened tone control most likely due to a lack of bioavailability, and the family decided to pursue pump and catheter revision. The patient’s preoperative examination exhibited bilateral upper-extremity (BUE) and bilateral lower-extremity (BLE) MRH paresis, hyperreflexia with clonus in all four extremities, with mAS grades of 3 in the BUE and 2 in the BLE. He spontaneously moved his BUE against gravity. He had a 144° LS dextroscoliosis with a moderate vertebral rotational component and a severe pelvic tilt (Fig. 1). FIG. 1.Preoperative computed tomography three-dimensional spinal reconstruction, anterior view, demonstrating 144° of LS scoliosis, moderate rotation, and severe pelvic tilt. The patient’s severe scoliosis could impede the intradural tunneling of the spinal catheter to the cervical level. L = left; R = right; S = superior. Preoperative computed tomography three-dimensional spinal reconstruction, anterior view, demonstrating 144° of LS scoliosis, moderate rotation, and severe pelvic tilt. The patient’s severe scoliosis could impede the intradural tunneling of the spinal catheter to the cervical level. L = left; R = right; S = superior. Surgical Course The patient’s hostile abdomen, an abdomen with intra- and extra-abdominal scarring that poses a high risk for neurosurgical devices (Fig. 2), necessitated alternative pump placement; his family declined options for placement in the thigh and back, so the right chest was selected inferior and lateral to the tracheostomy and contralateral to a VNS. A planned cervical catheter was most easily placed via a C1–2 puncture. FIG. 2.Photograph demonstrating an ileostomy bag (A), a jejunostomy tube (B), a gastrostomy tube (C), the pump location (D), and the intertriginous dressed skin wound (E) caused by a closed costopelvic angle. Photograph demonstrating an ileostomy bag (A), a jejunostomy tube (B), a gastrostomy tube (C), the pump location (D), and the intertriginous dressed skin wound (E) caused by a closed costopelvic angle. Following appropriate antibiosis, an incision was made at the right lateral neck, just below the mastoid process. The right lateral dura was accessed at C1–2, and fluoroscopy was used to guide needle placement, first with a 22-gauge needle and then with a coaxial 14-gauge Tuohy needle (Fig. 3). The catheter was easily passed; however, a downward trajectory was inhibited by a large mastoid. As a result, the catheter tip was positioned superiorly at the skull base (C0). An anchor was sewn to the fascia, and an epifascial right pectoral pocket was created via blunt dissection and Bovie electrocautery. The spinal catheter was tunneled and connected to the pump segment, which was connected to a 20-mL pump. The side port was injected with 10 mg vancomycin and 4 mg gentamicin, and each wound was irrigated with 1 L dilute betadine and 1 L vancomycin. One gram intrawound vancomycin powder was placed, and the wounds were closed with 3-0 Vicryl+ and 3-0 Monocryl+ sutures (Fig. 4). Following new pump and catheter placement, the original pump was removed, and the catheter system was tied off to prevent cerebrospinal fluid (CSF) egress. The patient was returned to the supine position and brought to the pediatric intensive care unit for monitoring, pain management, and reinitiation of feeds during the postoperative recovery. His new pump was programmed to the previous daily rate of 500 µg/day. The patient was given postoperative antibiotics and discharged on postoperative day 2. FIG. 3.Fluoroscopic confirmation of the puncture site at the C1–2 level. The right lateral dura was accessed first with a 22-gauge needle and then with a 14-gauge Tuohy needle. FIG. 4. A: Postoperative photograph of the cervical incision. B: Postoperative photograph of the anterior axillary incision and pectoral placement of the ITBP. Fluoroscopic confirmation of the puncture site at the C1–2 level. The right lateral dura was accessed first with a 22-gauge needle and then with a 14-gauge Tuohy needle. A: Postoperative photograph of the cervical incision. B: Postoperative photograph of the anterior axillary incision and pectoral placement of the ITBP. Postoperative Follow-Up Immediately postoperatively, the patient had BUE mAS grade 1, right lower extremity (RLE) mAS grade 1, and left lower extremity (LLE) mAS grade 2. At his 2-week follow-up, the patient’s mother reported that he had been doing well at home with no reports of pain. The physical examination was significant for BUE and BLE mAS grade 3. His pump was at 532.9 µg/day, and it was increased by 10.3% to 587.6 µg/day. At the 2-month follow-up, the patient was continuing to do well with no reports of pain, though his mother noted a recurrence of his seizures that began after placement of the ITBP. The patient had sustained BUE mAS grade 3, RLE mAS grade 2, and LLE mAS grade 3. At the last follow-up, the patient had simple continuous dosing of ITB at a rate of 860 µg/day and was discharged with as-needed follow-up. The patient was doing well with stably diminished tone at 1 year following ITBP revision. Informed Consent The necessary informed consent was obtained in this study. Discussion Observations We present the case of a 16-year-old male with severe quadriplegic mixed hypertonia secondary to CP, complicated by severe thoracolumbar scoliosis and SBS, leading to the need for new placement of an ITBP in the right pectoral area and catheter revision to the skull base via a C1–2 puncture. ITBP placement maintained previous tone control. Complex cases such as this pose unique clinical challenges worth discussing. Intrathecal Baclofen Therapy Since 1984, ITB therapy has been used to treat spasticity and dystonia in children, particularly in the setting of CP.7, 19–21 Baclofen is the only medication that has been approved by the US Food and Drug Administration for the treatment of spasticity via intrathecal drug delivery. In uncomplicated patients, ITBP placement is generally performed in a lateral decubitus position such that right or left abdominal pump implantation and midlumbar CSF catheter access is available. The spinal catheter is advanced to a desired level and anchored to the fascia. Once anchored, the catheter is tunneled to the pump, connected to a pump segment catheter, and connected to the pump. The entire system is implanted and the wounds are closed.22 Medical Complexity of ITB Therapy and Baclofen Withdrawal ITB therapy optimization is iterative and optimized when a therapeutic dose is reached without side effects. Thus, maintenance of the ITBP requires active participation from both the patient’s care team and family.23 Our patient’s multiple complex medical conditions precipitated an attempt to wean ITB therapy and pursue pallidotomy. A recent review demonstrated that bilateral pallidotomy led to improvement in symptoms in children with acquired or heredodegenerative generalized dystonia.24 Unfortunately, for our patient, the ITB therapy wean was complicated by diminished enteral baclofen bioavailability due to SBS.25 The upper small intestine, which includes the duodenum and jejunum, has the greatest absorptive capacity in the gastrointestinal system because of its large surface area and perfusion. Drugs that bypass absorption in the small intestine can be absorbed in the colon.26 Enteral baclofen is rapidly absorbed in the gastrointestinal tract.19 Specifically, absorption only occurs in the upper small intestine, with little to no contribution of the colon.27, 28 Thus, SBS limited the absorption of enteral baclofen. Chest Placement of ITBP Our patient’s unique body habitus and surgical history made the abdominal area a suboptimal environment for revision. Furthermore, he had a history of slow and complicated wound healing in his abdomen following surgeries. Ideal ITBP implantation should be deep to an area of clean skin and free from creases, contained within subcutaneous adipose tissue, away from bony prominences and pressure points, and positioned to maintain accessibility for refilling.13 In standard practice, ITBPs are placed subcutaneously in the anterior abdominal wall, but placements in alternative sites such as the iliac fossa, thigh, and chest have been successfully performed.13–15 The consensus between the family and surgical team was to place the pump in the right pectoral subcutaneous space. ITBP placement in the right pectoral pocket was successful in our case without complications, contributing to the growing body of literature on the feasibility of alternative sites for ITBP implantation. Cervical ITB Catheter Tip The placement of the ITBP catheter tip varies depending on the therapeutic goal for the patient. Studies have shown that the distribution of baclofen in the CSF decreases along the rostrocaudal axis, with lower concentrations in the cisternal CSF than in the lumbar CSF, which can direct dosages and catheter tip placement.29 Largely, the protocol for baclofen dosing follows general guidelines determined by the ITB Therapy Best Practices Expert Consensus Panel. Regardless of cervical or lumbar catheter tip placement, baclofen therapy is typically initiated with a concentration of 500 µg/mL and titrated upward or downward based on a patient’s clinical factors and response to treatment. Notably, bolus dosing is based on data from lumbar injections, so the panel recommends that clinicians exercise caution when delivering bolus doses when the catheter is in the upper thoracic or cervical region.23 The recommendations for catheter tip placement are T10–12 for the treatment of spastic diplegia, C5–T2 for the treatment of spastic quadriplegia, and C1–4 for the treatment of generalized secondary dystonia.30 Dystonic CP represents 4%–17% of all cases of CP. A recent systematic review supported the recommendation that high catheter tip placement can enhance efficacy for dystonia in patients with CP.31 Thus, the decision was made to target the ITB catheter tip to the cervical level to address the patient’s dystonia. A standard lumbar puncture in the surgical protocol for ITBP placement can be complicated by scoliosis.11 Children with CP often have associated scoliosis, with a reported incidence of 20%–64%.32, 33 Due to the patient’s severe thoracolumbar scoliosis, achieving a cervical tip location and tunneling to the chest pocket were both concerning. A C1–2 puncture was pursued as an alternative. The technique for C1–2 puncture has been described in detail elsewhere.6 We had some difficulty in aiming the catheter inferiorly due to the large overhang of the mastoid past the C1–2 space. This required a cephalad trajectory and thus directed the catheter cephalad toward the skull base. ITBP catheter placement in the third ventricle has been previously described through direct access, without tunneling from the cervical level. These studies report improvement in dystonia scores following therapy.34–36 However, the placement of a baclofen catheter at the skull base or in the fourth ventricle following upward advancement from a C1–2 puncture is not reported, nor is this directed catheter limitation caused by the large mastoid. At both his 2-week and 2-month follow-ups, the patient’s family reported no pain, complications during recovery, or indications of baclofen toxicity. Furthermore, our case may represent a new technique for intracranial access that avoids challenges associated with transcranial techniques.6, 8, 12 Lessons We present the case of a pediatric patient treated with ITBP with catheter placement at the skull base via C1–2 puncture and right pectoral pump placement for quadriplegic mixed MRH. Our case highlights medical and surgical decision-making for maintaining ITB therapy in a very complex patient. Given the prevalence of CP and potential comorbidities, it is critical to understand how ITB techniques can be adapted to accommodate each patient’s unique presentation. Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper. Author Contributions Conception and design: Raskin, Abdelmageed, Shahin. Acquisition of data: Raskin, Mukherjee, Abdelmageed. Analysis and interpretation of data: Raskin, Mukherjee, Shahin. Drafting the article: all authors. Critically revising the article: all authors. Reviewed submitted version of manuscript: all authors. Approved the final version of the manuscript on behalf of all authors: Raskin. Statistical analysis: Raskin. Administrative/technical/material support: Raskin. Study supervision: Raskin, Abdelmageed. Correspondence Jeffrey S. Raskin: Ann & Robert H. Lurie Children’s Hospital, Chicago, IL. jraskin@luriechildrens.org.